Literature DB >> 2045103

Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome.

P J Scambler1, A H Carey, R K Wyse, S Roach, J P Dumanski, M Nordenskjold, R Williamson.   

Abstract

DiGeorge syndrome (DGS) is a developmental field defect of the third and fourth pharyngeal pouches. It is associated with deletion of 22q11 in 11% of cases. Molecular genetic analysis with probes from 22q11-pter reveals that a subset of markers is hemizygous in DGS patients with normal karyotypes. There is no apparent difference in the phenotype or the severity of the disorder between patients with the smallest detectable submicroscopic deletion and those with the largest cytogenetically visible abnormality. A microdeletion was found in a mildly affected child and in the severely affected child of a mildly affected father. Dysmorphology, especially cardiac outflow tract anomalies, resulting from 22q11 deletion may be more common than currently realized since chromosomes are unlikely to be checked if the complete spectrum of DGS is not present. Antenatal diagnosis, through detection of hemizygosity at 22q11, will be a possibility for mildly affected parents unwilling to risk the birth of a severely affected child.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045103     DOI: 10.1016/0888-7543(91)90501-5

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  70 in total

1.  A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11.

Authors:  D A Driscoll; M L Budarf; B S Emanuel
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

Review 2.  Molecular genetics of mineral metabolic disorders.

Authors:  R V Thakker
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 3.  Genetics of endocrine and metabolic disorders: parathyroid.

Authors:  R V Thakker
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

4.  Characterization and mapping of the 5' portion of von Willebrand factor pseudogene.

Authors:  P Patracchini; G Marchetti; V Aiello; G Croci; E Calzolari; F Bernardi
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

5.  Chromosome 22q11.2 deletion syndrome: an underestimated cause of neuropsychiatric impairment in adolescence.

Authors:  Dimitrios Parissis; Ioannis Milonas
Journal:  J Neurol       Date:  2005-07-27       Impact factor: 4.849

6.  High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping.

Authors:  Daniel A Peiffer; Jennie M Le; Frank J Steemers; Weihua Chang; Tony Jenniges; Francisco Garcia; Kirt Haden; Jiangzhen Li; Chad A Shaw; John Belmont; Sau Wai Cheung; Richard M Shen; David L Barker; Kevin L Gunderson
Journal:  Genome Res       Date:  2006-08-09       Impact factor: 9.043

7.  Evaluation of potential modifiers of the palatal phenotype in the 22q11.2 deletion syndrome.

Authors:  Deborah A Driscoll; Torrey Boland; Beverly S Emanuel; Richard E Kirschner; Don LaRossa; Jeanne Manson; Donna McDonald-McGinn; Peter Randall; Cynthia Solot; Elaine Zackai; Laura E Mitchell
Journal:  Cleft Palate Craniofac J       Date:  2006-07

Review 8.  A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: implications for clinical evaluation and treatment.

Authors:  Opal Ousley; Kimberly Rockers; Mary Lynn Dell; Karlene Coleman; Joseph F Cubells
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

Review 9.  Recent developments in the application of the nonverbal learning disabilities model.

Authors:  Brenna C McDonald
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

10.  Noonan's and DiGeorge syndromes with monosomy 22q11.

Authors:  D I Wilson; S B Britton; C McKeown; D Kelly; I E Cross; S Strobel; P J Scambler
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.